Modified Antibodies Boost Photodynamic Therapy’s Efficacy - IDEX Health & ScienceIDEX Health & Science


    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Modified Antibodies Boost Photodynamic Therapy’s Efficacy

    Article obtained from BioPhotonics RSS Feed.

    Adding antibodies to photodynamic therapies can bolster their efficacy, according to research conducted by Texas A&M University and the University of São Paulo. The work reviewed the existing approaches to photodynamic therapies and provided a model to help expedite development of photodynamic therapies as a rapid response to emergent pandemics.

    In photodynamic therapy (PDT), photosensitizers composed of dyes and other light-reacting compounds are typically administered intravenously or are applied topically to the area where treatment is needed; they are then absorbed by microbes or cancer cells. When light is applied, the compounds react, forming reactive oxygen species — toxic oxygen molecules that kill the cancer…

    May, 25 2021 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.